Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range of doses sold online to try to stave off competition from compounding ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results